PTO, Patent Challenger Tell Panel To Reject Due Process Arguments

Mealey's (November 11, 2020, 10:38 AM EST) -- WASHINGTON, D.C. — In an Oct. 27 intervenor brief, the U.S. Patent and Trademark Office (PTO) argues that the funding mechanism associated with the Patent Trial and Appeal Board (PTAB) is...
To view the full article, register now.